FEIFAN Biopharma took its name from Mr. Tang Feifan, who is the father of vaccine in China for paying our tribute to the pioneer, who explored the frontier of China’s biopharma. Funded by Changchun New Area government, FEIFAN, as an integrated CDMO platform, is committed to regional, national, and global delivery of macromolecular and small molecule drugs with business scope ranging from process development and optimization, pilot scale production of samples for clinical use, to commercial manufacturing in compliance of GMP.

FEIFAN Biopharma took its name from Mr. Tang Feifan, who is the father of vaccine in China for paying our tribute to the pioneer, who explored the frontier of China’s biopharma. Funded by Changchun New Area government, FEIFAN, as an integrated CDMO platform, is committed to regional, national, and global delivery of macromolecular and small molecule drugs with business scope ranging from process development and optimization, pilot scale production of samples for clinical use, to commercial manufacturing in compliance of GMP.

FEIFAN Biopharma took its name from Mr. Tang Feifan, who is the father of vaccine in China for paying our tribute to his pioneering work. With Changchun New Area Government as one investors, FEIFAN is an integrated CDMO platform and committed to regional, national, and global delivery of macromolecular and small molecule drugs with business scope ranging from process development and optimization, pilot scale production of samples for clinical use, to industrial production in compliance of GMP.